welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology
Thetis Pharmaceuticals LLC, a privately-held biopharmaceutical company focused on gastrointestinal and cardiometabolic diseases, announced today that the USPTO has granted patent US 9,242,008 providing composition of matter protection for two Thetis development candidates, TP-252 for familial adenomatous polyposis and TP-452 for dyslipidemia. The allowed claims include pharmaceutical compositions that are mineral amino-acid based derivatives of fatty acids. National filings outside of the United States are underway.
expertly curated content related to this topic
- Stages and Evaluation of Surgical Innovation: A Clinical Example of the Ileo Neo Rectal Anastomosis After Ulcerative...AIM: So far, not many clinical examples...
- Vanderbilt – Ingram Cancer CenterVanderbilt-Ingram Cancer Center is one o...
- How to Defy a Hereditary Predisposition and Prevent Colon Cancerhttps://www.youtube.com/watch?v=IynYbT2i...
- Miguel A. Rodriguez-Bigas, MDProfessor, Department of Surgical Oncolo...
- Colectomyhttp://www.mayoclinic.org/~/media/kcms/g...
- Lucio BertarioDr. Lucio Bertario is the Head of the Un...
- Deborah I. Barragan, MS, CGCGenetic Counselor Education: MS, Human G...
English
Portuguese
Spanish